AKT1 and hepatocellular carcinoma: Highly expressed SNORD126 can promote cell proliferation and thus promote the development of HCC by regulating the PI3K/AKT pathway via activation of AKT phosphorylation and increasing fibroblast growth factor receptor 2 (FGFR2) expression (66).